Ep. 112 - Chris Arendt on rebuilding Takeda for AI

Chris Arendt, CSO of Takeda, likens the AI overhaul at the pharma to gutting and rebuilding an old house, from the plumbing and electrical up, while you’re still living there. In a Fireside Chat at Grand Rounds U.S. in Seattle, Arendt sat down with Editor in Chief Simone Fishburn to discuss how Takeda is integrating AI across R&D, in and beyond the science, while still executing on the active programs in drug development.View full story: https://www.biocentury.com/article/659807#ArtificialIntelligence #PharmaInnovation #DrugDevelopment #DigitalTransformation #ResearchAndDevelopment00:00 - Introduction02:07 - Revamping Takeda for AI19:03 - Teams & Talent26:43 - Alliances32:50 - Q&A